New High-Resolution Computer Tomography Data Demonstrates EVISTA(R)’s Effect on Bone Quality in Osteoporotic Patients

3D Images Provide New Approach to Monitoring Bone Changes
MUNICH, June 28, 2010 – Interim data from a prospective Investigator Initiated Trial
(IIT) presented today at the ECTS, the 37th European Symposium on Calcified
Tissues, in Glasgow, demonstrates that EVISTA(R) (raloxifene 60mg;
once-daily, distributed in 34 countries by DAIICHI SANKYO), indicated for the
treatment and prevention of osteoporosis in [...]

Kowa Company, Ltd. Grants Abbott Exclusive Rights to Market Pitavastatin Calcium, a Lipid-lowering Drug, in Australia and New Zealand

WOKINGHAM, England, June 28, 2010 – Following an enthusiastic expansion programme into new markets, Kowa
Company, Ltd. (President: Yoshihiro Miwa), headquartered in Nagoya, Japan,
has granted Abbott, headquartered in Illinois, USA the exclusive license to
distribute and market pitavastatin calcium (brand name Livalo), a
lipid-lowering drug, in Australia and New Zealand. This agreement means that
pitavastatin will now be [...]

Enzymes Gain Importance as Process Aids in Food Applications, Finds Frost & Sullivan

LONDON, June 28, 2010 – During the economic slowdown in 2009, food enzymes were successfully
positioned as cost savers and process efficiency improvers in many
application segments. This strategy, along with increased R&D efforts, is
expected to continue to attract new applications such as interesterification
for the reduction of trans fats and as 'meat glue' (transglutaminases). While
the increased [...]

Chasing Happiness: Why Feeling Good Remains Elusive

SAN FRANCISCO, June 28, 2010 – Want happiness? While studies indicate that lots of friends, a high
paying job, or even passing years may create a higher likelihood of feeling
"happy," a reliable recipe for lasting happiness remains elusive, says The
Gnostic Movement. Lasting happiness will be the focus of a global Gnostic
event on July 10 in [...]

Gastrointestinal Disorders Therapeutics to 2016 – High Unmet Needs Triggering Strong Growth in Crohn’s Disease and Irritable Bowel Syndrome Markets Now Available at ReportsandReports

DALLAS, June 28, 2010 – ReportsandReports announces it will carry the Gastrointestinal Disorders
Therapeutics to 2016 – High Unmet Needs Triggering Strong Growth in Crohn's
Disease and Irritable Bowel Syndrome Markets Market Research Report in its
store.

Browse the complete Report on:
www.reportsandreports.com/market-reports/gastrointestinal-disorders-th
erapeutics-to-2016-high-unmet-need/
GBI Research's report, "Gastrointestinal disorders therapeutics, analysis
and forecasts to [...]

Indian Multinational Company Confirms USD 6 Million Order to Set up Industrial Waste Water Treatment Plants in Africa

CHENNAI, India, June 28, 2010 – Shivsu Canadian Clear International Ltd, a leading water technology
solution provider, has completed an order worth USD 6 million from the
private organizations and Government of Africa to set up industrial waste
water treatment plants in Kenya, Tanzania and Ethiopia. The company will be
involved in design, manufacture, supply and installation of [...]

Astellas Announces Oral Presentation of SGLT2 Inhibitor Detailing Safety and Efficacy in Patients With Type 2 Diabetes at the American Diabetes Association Meeting

TOKYO, June 28, 2010 – Astellas Pharma Inc. (Headquarters: Tokyo, President & CEO: Masafumi
Nogimori, "Astellas") announced that the company presented results from a
Japanese Phase 2 study conducted with ASP1941, a selective SGLT2 inhibitor,
at the 70th Scientific Sessions of the American Diabetes Association (ADA) on
June 26, 2010 (EST). ASP1941 is designed to block the re-absorption [...]

The National Institute for Health & Clinical Excellence (NICE) Approves the Use of Radiofrequency Ablation for Treatment of Barrett’s Esophagus

Interventional Procedures (IPAC) Guidelines from NICE in the UK include Radiofrequency Ablation (RFA) for eradication of high grade dysplasia in patients with Barrett's Esophagus.

SUNNYVALE, California, June 28, 2010 – BARRX Medical Inc., a world leader in products to treat pre-cancerous
tissue in the esophagus, reported today that the National Institute for
Health and Clinical Excellence (NICE) [...]

Power Market in Western Europe to 2020 – Increasing Focus on Renewable Power to Change the Energy Mix Now Available at ReportsandReports

DALLAS, June 28, 2010 – ReportsandReports announces it will carry the Power Market in Western
Europe to 2020 – Increasing Focus on Renewable Power to Change the Energy Mix
Market Research Report in its store.

Browse the complete Report on:
www.reportsandreports.com/market-reports/power-market-in-western-europ
e-to-2020-increasing-focus-on-rene/
GBI Research's report, "Power Market in Western Europe to 2020:
Increasing [...]

Upsher-Smith Laboratories Adds ITI-111 (Nasal Midazolam) to CNS Development Pipeline

Second Deal in Six Months Expands CNS Portfolio to Four Programs
MAPLE GROVE, Minnesota, June 28, 2010 – Upsher-Smith Laboratories, Inc. today announced an agreement with Ikano
Therapeutics, Inc. to obtain exclusive global rights to ITI-111, Ikano's
nasal midazolam. Under terms of the agreement, Upsher-Smith will assume all
further development, testing and clinical study of nasal midazolam as [...]

Findings From Global Survey Help Understand Fertility Trends And Barriers to Seeking Medical Help Against Infertility

Over 10,000 Responded to the Largest International Study Aimed at Understanding the Decision-making Process of Couples Trying to Conceive

ROME, June 28, 2010 – Merck Serono, a division of Merck KGaA, Darmstadt, Germany, today
announced the outcomes of the Global survey "Starting Families" at the 26th
edition of the annual meeting of the European Society of Human [...]

Frankfurt To Host World’s Largest Pharmaceutical Services Events In 2011

AMSTERDAM, June 28, 2010 – Leading events organiser UBM International Media today announced that its
flagship CPhI Worldwide tradeshow will return to Frankfurt, Germany for 2011.
Along with co-hosted events – P-MEC Europe for equipment, machinery and
technology; ICSE for contract services and packaging; and BioPh Europe for
the biopharma sector – the world's leading pharma services industry [...]

Mr. Jean-Pierre Garnier Concludes his Mission at the Pierre Fabre Company

CASTRES, France, June 28, 2010 – Mr Jean-Pierre Garnier will step down on September 1st 2010,
two years after having been appointed CEO of the Pierre Fabre Group.

"The Company is in excellent health, and is poised to
experience a bright future ; I am glad to have contributed to its success and
I [...]

Twelve Women Scientists Announced as Winners of Elsevier Foundation TWOWS Awards

Outstanding Young Women Biologists, Chemists, Physicists and Mathematicians Recognized Across the Developing World

BEIJING, June 27, 2010 – The Elsevier Foundation, TWAS and TWOWS announced today that they are
recognizing twelve talented women scientists from Africa, the Middle East,
Asia, Latin America and the Caribbean for their research excellence. The
announcement was made at the Third World Organization [...]

Results From Study of Vascular Calcification in Dialysis Patients Presented in Late-Breaking Clinical Trial Session at ERA-EDTA 2010 Congress

MUNICH, June 26, 2010 – Results from the ADVANCE study presented in a late breaking clinical
trial session at the ERA-EDTA 2010 Congress provide new insights into the
management of secondary hyperparathyroidism (SHPT) in chronic kidney disease
(CKD) patients. ADVANCE (A randomiseD VAscular calcificatioN study to
evaluate the effects of CinacalcEt) is a randomised, controlled open label
study to [...]

ONGLYZA(TM) (saxagliptin) With Metformin As Initial Combination Therapy Provided 76-Week Long-Term Glycemic Control In Treatment-Naive Adults With Type 2 Diabetes

Not for US Media
ORLANDO, Florida, June 26, 2010 – Bristol-Myers Squibb Company (NYSE: BMY)
and AstraZeneca (NYSE: AZN) today announced results up to 76-weeks from a
Phase 3 study of ONGLYZA(TM) (saxagliptin) as initial combination therapy
with metformin, which produced long-term glycemic improvement [as measured
by glycosylated hemoglobin level (HbA1c)] in treatment-naive adults with
type 2 diabetes mellitus inadequately [...]

52-Week Study Finds ONGLYZA(TM) (saxagliptin) When Added To Metformin Was Non-Inferior To Titrated Glipizide When Added To Metformin In Reducing Glycosylated Hemoglobin (HbA1c) In Adults With Type 2 Diabetes Mellitus

Not for US Media
ORLANDO, Florida, June 26, 2010 – Bristol-Myers Squibb Company (NYSE: BMY)
and AstraZeneca (NYSE: AZN) today announced results from a 52-week Phase 3b
study in adults with type 2 diabetes who had inadequate glycemic control on
metformin therapy plus diet and exercise. This study found that the addition
of ONGLYZA(TM) (saxagliptin) 5 mg to existing [...]

Dapagliflozin As Add On Therapy To Insulin Demonstrated Improved Glycemic Control In Patients With Type 2 Diabetes Inadequately Controlled With Insulin

Not for US Media
ORLANDO, Florida, June 26, 2010 – Results from a 24-week Phase 3 clinical
study demonstrated that the addition of the investigational drug
dapagliflozin achieved reductions in the primary endpoint, glycosylated
hemoglobin level (HbA1c), in inadequately controlled type 2 diabetes patients
who were treated with insulin (with or without oral anti-diabetes medications
(OADs)), compared to placebo plus [...]

Merck Serono Calls for Entries to Real MS – Your Story, a Global Competition to Raise Awareness of Multiple Sclerosis

Campaign Website and Global Script Concept Competition Launch Today
GENEVA, June 25, 2010 – Merck Serono, a division of Merck KGaA, Darmstadt, Germany,
today announces the start of the Real MS: Your Story competition, with the
campaign website (www.realmsvoices.com) now open for entry
submissions. Real MS: Your Story is the first element of Real MS, a global
multiple sclerosis [...]

Shire Receives CHMP Positive Opinion for VPRIV(TM) (velaglucerase alfa) for the Treatment of Type 1 Gaucher Disease in the European Union

CAMBRIDGE, Massachusetts, June 25, 2010 – Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty
biopharmaceutical company, announced today that the Committee for Medicinal
Products for Human Use (CHMP) of the European Medicines Agency adopted a
positive opinion on the marketing authorisation for VPRIV(TM) (velaglucerase
alfa), the company's enzyme replacement therapy (ERT) for the treatment of
type 1 Gaucher [...]

Serono Symposia International Foundation in Collaboration With ESHRE Announces Public Competition in Reproductive Medicine

ROME, June 29, 2010 – Serono Symposia International Foundation (SSIF), has announced
today a public competition for an award to recognise an expert in bioscience
who has made a significant contribution to medical education activities in
recent years. The ideal candidate has the potential to play a major role in
spreading science and has made outstanding contributions to [...]

Elsevier Announces New Access to Reaxys(R) To Raise Performance And Output For Chemists at Sapienza University of Rome

FRANKFURT, June 29, 2010 – Elsevier and Sapienza University of Rome today announced a new
agreement, providing researchers at the university with access to Reaxys
(www.info.reaxys.com/), Elsevier's workflow solution for research
chemists. Reflecting the way chemists think and work, Reaxys will enable
researchers at Sapienza to quickly find the chemistry relevant for their
needs and thereby raise their performance [...]

Disease and Therapy Review: Colorectal Cancer Now Available at ReportsandReports

DALLAS, June 29, 2010 – ReportsandReports announces it will carry the Disease and Therapy Review:
Colorectal Cancer Market Research Report in its store.

Browse the complete Report on:
www.reportsandreports.com/market-reports/disease-and-therapy-review-co
lorectal-cancer/
The Colorectal Cancer Disease and Therapy Review provides an overview of
the disease and related conditions, with incidence, prevalence and mortality
numbers and [...]

Disease and Therapy Review: Bladder Cancer Now Available at ReportsandReports

DALLAS, June 29, 2010 – ReportsandReports announces it will carry the Disease and Therapy Review:
Bladder Cancer Market Research Report in its Store

Browse the complete Report on:
www.reportsandreports.com/market-reports/disease-and-therapy-review-bl
adder-cancer/
The Bladder Cancer Disease and Therapy Review provides an overview of the
disease and related conditions, with incidence, prevalence, and mortality
numbers and [...]

Disease and Therapy Review: Impetigo Now Available at ReportsandReports

ReportsandReports Announces it Will Carry the Disease and Therapy Review: Impetigo Market Research Report in its Store.

DALLAS, Texas, June 29, 2010 – Browse the complete Report on:
www.reportsandreports.com/market-reports/disease-and-therapy-review-im
petigo/
The Impetigo Disease and Therapy Review provides an overview of the
disease, with incidence and prevalence estimates for major countries
worldwide Information on diagnosis, and an [...]

Disease and Therapy Review: Asthma Now Available at ReportsandReports

ReportsandReports Announces it Will Carry the Disease and Therapy Review: Asthma Market Research Report in its Store.

DALLAS, June 29, 2010 – Browse the complete Report on:
www.reportsandreports.com/market-reports/disease-and-therapy-review-as
thma/
The Asthma Disease and Therapy Review provides an overview of the disease
and related conditions, with incidence and prevalence numbers and percentages
for major countries worldwide, information [...]

Disease and Therapy Review: Onychomycosis Now Available at ReportsandReports

DALLAS, June 29, 2010 – ReportsandReports announces it will carry the Disease and Therapy Review:
Onychomycosis Market Research Report in its store.

Browse the complete Report on:
www.reportsandreports.com/market-reports/disease-and-therapy-review-on
ychomycosis/
The Onychomycosis Disease and Therapy Review provides an overview of the
disease and subtypes, with incidence and prevalence numbers and percentages
for major countries [...]

Disease and Therapy Review: Ulcerative Colitis Now Available at ReportsandReports

DALLAS, June 29, 2010 – ReportsandReports announces it will carry the Disease and Therapy Review:
Ulcerative Colitis Market Research Report in its store.

Browse the complete Report on:
(www.reportsandreports.com/market-reports/disease-and-therapy-review-
ulcerative-colitis/)
The Ulcerative Colitis Disease and Therapy Review provides an overview of
the disease and related conditions, with incidence prevalence information for
major countries [...]

Cardio3 BioSciences Reports Positive Three-Month Data From its Clinical Trial of C-Cure(R) in Heart Failure

MONT-SAINT-GUIBERT, Belgium, June 29, 2010 – Cardio3 BioSciences, a leading Belgian biotechnology company specialising
in regenerative therapies for the treatment of cardiovascular diseases, today
announces positive safety data and preliminary efficacy results from its
clinical trial of C-Cure(R), a breakthrough stem cell therapy for heart
failure.

Results showed C-Cure to have a very good safety [...]

Assist America Announces Formation of Assist America Middle East

PRINCETON, New Jersey, June 29, 2010 – Assist America announced today the formation of Assist America Middle
East and North Africa (AAME), to be headquartered in Beirut, Lebanon. AAME
will serve as the exclusive marketing arm for Assist America in the Middle
East and North Africa. The company's focus is to expand Assist America's
global emergency services in [...]

Frost & Sullivan Lauds FCMB ApS for Its Breakthrough Work in Non-invasive Prenatal Testing

LONDON, June 30, 2010 – Frost & Sullivan is pleased to announce that it has awarded its
prestigious 2010 Scandinavia New Product Innovation Award to FCMB ApS
("FCMB") for its breakthrough work in non-invasive prenatal testing. FCMB is
developing a suite of non-invasive prenatal diagnostics based on isolating
fetal cells from maternal blood samples. FCMB's diagnostics have the
potential [...]

Centris AG – Strong Customer Support Thanks to CA Technologies

The Leading Swiss IT Service Provider for Health and Accident Insurers Relies on CA Service Desk Manager to Pursue a No-compromise Policy When it Comes to Top Quality Customer Support

ZURICH, June 30, 2010 – The leading Swiss IT service provider for health and accident insurers,
Centris AG, based in Solothurnsupports around 4,500 users in [...]

Simbionix and USF Receive Grant to Support Development of Laparoscopic Hysterectomy Simulation

CLEVELAND, Ohio, June 30, 2010 – Simbionix Ltd., a subsidiary of Simbionix USA Corporation, the world's
leading provider of medical education and simulation training products for
medical professionals and the healthcare industry, and USF Health, an
organization dedicated to creating a model of health care based on
understanding the full spectrum of health, are proud to announce that
together [...]

Over 40,000 Food Professionals at FiA | Hi | Ni China 2010

SHANGHAI, June 30, 2010 – FiA | Hi | Ni China 2010, alongside Food Ingredients Shanghai (FIS 2010)
and CPhI China 2010, kicked off at Shanghai New International Expo Center on
June 2nd-4th, 2010. Professionals from the global food's raw materials and
ingredients market gathered under one roof in the main event of the industry.

[...]

Shire Purchases Strategic Site in Massachusetts

Transaction Allows Company to Continue its Growth
LEXINGTON, Massachusetts, June 30, 2010 – Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty
biopharmaceutical company, today announced its purchase of the Lexington
Technology Park campus in Lexington, Massachusetts. The purchase signifies an
investment in the growth of its Human Genetic Therapies (HGT) business, which
focuses on the discovery, development, and [...]

Taking Fundraising to New Heights – MediciGlobal’s Global eMarketing Director Jumps from 10,000 feet for Alzheimer’s Research

MediciGlobal team members lead the way in 'Extreme Charity'
KING OF PRUSSIA, Pennsylvania, and LONDON, June 30, 2010 – Participating in 'extreme charity' events aptly describes the commitment
of MediciGlobal's employees to raising money for noteworthy causes. Last
year, one of MediciGlobal's new project leaders climbed Kilimanjaro for
cancer research, and this year, the same executive is embarking [...]

Celsis Seeks Injunction Against Invitrogen for LiverPool(TM) Patent Infringement

BALTIMORE, June 30, 2010 – Celsis In Vitro, Inc. (Celsis IVT) announced today that it has filed a
patent infringement lawsuit against Invitrogen Corporation (Invitrogen) and
CellzDirect, Inc. (CellzDirect) in the United States District Court for the
Northern District of Illinois in Chicago and has moved for a preliminary
injunction. Invitrogen, the parent of CellzDirect, is itself a [...]

Gen-Probe Receives European CE Mark for Molecular Test to Detect Common Sexually Transmitted Disease Trichomonas Vaginalis

SAN DIEGO, June 30, 2010 – Gen-Probe Incorporated (Nasdaq: GPRO) announced today that it has
received a European CE mark for its APTIMA(R) assay for Trichomonas
vaginalis, a common parasitic sexually transmitted disease.

Gen-Probe's APTIMA Trichomonas assay utilizes the same nucleic acid
amplification technologies as the APTIMA COMBO 2(R) assay, the Company's
market-leading test for [...]

Eiger BioPharmaceuticals Announces New HCV Synergy Data

Publication describes high level of synergy of clemizole with protease inhibitor class

PALO ALTO, California, July 1, 2010 – Eiger BioPharmaceuticals, Inc., a biotechnology company developing
antiviral therapies, announced today the publication of research from the lab
of Stanford scientist and Eiger Founder, Dr. Jeffrey Glenn, M.D., Ph.D. and
colleagues entitled, "The Hepatitis C Virus (HCV) NS4B RNA [...]